Enjalbert F., Rapior S., Nouguier-Soulé J., Guillon S., Amouroux N., Cabot C. Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol Clin Toxicol. 2002;40(6):715-57.
Rationale
Amatoxin poisoning is the deadliest mushroom intoxication: a long latent phase (6–24 h), gastroenteritis, a deceptive "recovery", then hepatotoxicity, liver failure and coma. The toxins — α-, β-, γ-amanitins — are bicyclic octapeptides that irreversibly block RNA polymerase II. By 2002 no prospective RCT of therapy existed — and likely never will: cases are rare and scattered.
Methods
All published clinical data on hospitalised amatoxin poisonings in North America and Europe over ~20 years — 2,108 cases. Supportive measures and 10 specific treatment regimens (detoxification: forced diuresis, biliary drainage, extracorporeal purification; chemotherapy: benzylpenicillin and other β-lactams, silymarin, thioctic acid, antioxidants, hormones and steroids) were compared against mortality by chi-square analysis.
Results
- Benzylpenicillin (penicillin G) was the most used drug — but showed little efficacy.
- Thioctic acid and steroids — no benefit.
- Silybin (intravenous, alone or combined) and N-acetylcysteine (monotherapy) — the only regimens statistically associated with survival.
- 35 amatoxin-containing species across three genera: Amanita, Galerina, Lepiota — "little brown mushrooms" are as dangerous as the death cap.
Authors' conclusions
The best candidates for standard therapy are silybin and NAC plus aggressive supportive care; prospective studies should confirm efficacy.
Worth noting
Enjalbert's analysis is the de facto foundation of the modern protocol: afterwards, intravenous silibinin (Legalon SIL in Europe, IND in the US) plus NAC became the standard. Twenty years on, no prospective RCT has appeared — rarity makes one nearly impossible. Retrospective design is biased: the sickest patients received everything at once, so the "combination effect" may be an artefact. But no dataset of this scale exists or is likely to.